GTEx AdrenalGland 20-29 vs 50-59 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx AdrenalGland 20-29 vs 50-59 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx AdrenalGland 20-29 vs 50-59 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx AdrenalGland 20-29 vs 50-59 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx AdrenalGland 20-29 vs 50-59 Up.

Results found

Linked to

 

Label

Description

 

Gene

POU class 3 homeobox 3

Gene

p53 upregulated regulator of p53 levels

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

LIF antisense RNA 2

Gene

MT-ND1 pseudogene 23

Gene

cytochrome P450 family 4 subfamily F member 29, pseudogene

Gene

lncRNA osteogenesis associated

Gene

SLCO4A1 antisense RNA 1

Gene

S-phase cancer associated transcript 8

  • Gene

    POU class 3 homeobox 3


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    LIF antisense RNA 2


  • Gene

    MT-ND1 pseudogene 23


  • Gene

    cytochrome P450 family 4 subfamily F member 29, pseudogene


  • Gene

    lncRNA osteogenesis associated


  • Gene

    SLCO4A1 antisense RNA 1


  • Gene

    S-phase cancer associated transcript 8

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.